CRIS Current Research Information System

VIGNATELLI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.898
AS - Asia 3.635
EU - Europa 2.626
AF - Africa 210
SA - Sud America 175
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.555
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.809
SG - Singapore 1.006
CN - Cina 897
VN - Vietnam 889
GB - Regno Unito 621
IT - Italia 460
DE - Germania 324
SE - Svezia 300
HK - Hong Kong 235
UA - Ucraina 183
IN - India 161
FR - Francia 157
BR - Brasile 127
RU - Federazione Russa 127
KR - Corea 113
BD - Bangladesh 106
IE - Irlanda 89
NL - Olanda 89
FI - Finlandia 80
TG - Togo 80
JP - Giappone 65
CA - Canada 54
ZA - Sudafrica 45
CI - Costa d'Avorio 32
EE - Estonia 28
BE - Belgio 27
CH - Svizzera 27
ES - Italia 25
SC - Seychelles 25
PK - Pakistan 23
AR - Argentina 22
MX - Messico 21
PH - Filippine 20
TH - Thailandia 18
BG - Bulgaria 16
AT - Austria 14
ID - Indonesia 13
PL - Polonia 13
JO - Giordania 12
UZ - Uzbekistan 12
TW - Taiwan 11
CO - Colombia 10
RO - Romania 10
GR - Grecia 9
IQ - Iraq 9
LT - Lituania 8
TR - Turchia 8
SA - Arabia Saudita 6
TN - Tunisia 6
CL - Cile 5
IR - Iran 5
NZ - Nuova Zelanda 5
EG - Egitto 4
HR - Croazia 4
LB - Libano 4
MA - Marocco 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
EC - Ecuador 3
GH - Ghana 3
MY - Malesia 3
NG - Nigeria 3
PT - Portogallo 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
KW - Kuwait 2
LV - Lettonia 2
PE - Perù 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
HU - Ungheria 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
Totale 11.551
Salva come PNG Salva come JPEG
Città #
Singapore 723
Ashburn 599
Southend 505
Chandler 318
Ann Arbor 252
Fairfield 252
Hefei 248
Ho Chi Minh City 225
Santa Clara 223
Hong Kong 219
San Jose 213
Hanoi 201
Dallas 188
Jacksonville 132
Houston 130
Woodbridge 130
Wilmington 125
Los Angeles 124
Seattle 111
Princeton 107
New York 105
Boardman 101
Seoul 98
Cambridge 96
Council Bluffs 91
Beijing 89
Dublin 88
Bologna 82
Lomé 80
Helsinki 68
Dong Ket 63
Tokyo 62
Lauterbourg 55
Padova 45
Westminster 44
Milan 39
Berlin 38
Turin 36
Redmond 35
Jinan 34
Nanjing 33
Abidjan 32
Haiphong 32
São Paulo 32
Da Nang 31
Orem 30
Bengaluru 28
Buffalo 28
Brussels 27
Denver 27
Phoenix 27
Chicago 26
Saint Petersburg 26
Bern 24
San Francisco 24
Brooklyn 23
London 23
Shenyang 23
Atlanta 21
Medford 21
Rome 21
Redondo Beach 19
Montreal 18
Hebei 17
Mülheim 17
Redwood City 17
Tianjin 17
San Diego 16
Sofia 16
Toronto 15
Yubileyny 15
Des Moines 14
Mahé 14
Johannesburg 13
Lahore 13
Frankfurt am Main 12
Guangzhou 12
Munich 12
Nanchang 12
Zhengzhou 12
Amman 11
Boston 11
Verona 11
Amsterdam 10
Can Tho 10
Changsha 10
Jiaxing 10
Nha Trang 10
Norwalk 10
Shanghai 10
Chengdu 9
Hải Dương 9
Lappeenranta 9
Las Vegas 9
Naples 9
Olalla 9
Vienna 9
Washington 9
Xi'an 9
Bangkok 8
Totale 7.406
Salva come PNG Salva come JPEG
Nome #
Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. 968
The Arousal Disorders Questionnaire: a new and effective screening tool for confusional arousals, Sleepwalking and Sleep Terrors in epilepsy and sleep disorders units 323
Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment 257
A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. 248
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System 230
Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis 225
Community-onset pediatric status epilepticus: Barriers to care and outcomes in a real-world setting 215
Excessive daytime sleepiness and subjective sleep quality in patients with nocturnal frontal lobe epilepsy: a case-control study. 213
Mesial temporal lobe epilepsy (MTLE): prognostic factors 210
Magnetic resonance imaging scoring system of the lower limbs in adult patients with suspected idiopathic inflammatory myopathy 208
Memoria semantica durante il sonno REM di pazienti narcolettici 204
Medico-legal assessment of disability in narcolepsy: an interobserver reliability study 202
Role of Daytime Continuous Polysomnography in the Diagnosis of Pediatric Narcolepsy Type 1 197
Parasomnias versus epilepsy: common grounds and a need to change the approach to the problem. 192
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: A prospective study 192
Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management 192
Prognostic factors in patients with mesial temporal lobe epilepsy 189
Sex disparities in clinical features and burden of narcolepsy type 1 188
Antidepressant drugs for narcolepsy 188
Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep. 188
Quantitative dried blood spot microsampling for therapeutic drug monitoring of -antiseizure medications by design of experiment and UHPLC-MS/MS 185
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study 185
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 184
Semantic memory during REM sleep of narcoleptic patients 182
Quality of life, eating and mood disorders in menstrual migraine: a case-control study 182
Protocols of a diagnostic study and a randomized controlled non-inferiority trial comparing televisits vs standard in-person outpatient visits for narcolepsy diagnosis and care: TElemedicine for NARcolepsy (TENAR) 179
Diagnosis of Nocturnal Frontal Lobe Seizures: The Diagnostic Accuracy of Clinical History. 178
Patient-centred estimation of multimorbidity in chronic disease populations: a novel approach integrating global burden of disease metrics and healthcare administrative data 176
Work productivity and activity impairment in patients with narcolepsy type 1 172
Memoria procedurale e dichiarativa durante il sonno di pazienti narcolettici 172
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. 171
Minimal hepatic encephalopathy: longitudinal effects of liver transplantation. 170
Interobserver reliability of ICSD-3 diagnostic criteria for disorders of arousal in adults 169
Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment 169
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 169
Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. 167
Antidepressant drugs for narcolepsy. 165
Sleep and time course of consolidation of visual discrimination skills in patients with narcolepsy-cataplexy. 163
Interobserver reliability of ICSD-R minimal diagnostic criteria for the parasomnias. 162
Health-related quality of life in patients with Nocturnal Frontal Lobe Epilepsy. 155
Epidemiology of status epilepticus in a rural area of northern Italy: a 2-year population-based study 155
Interobserver reliability of video recording in the diagnosis of nocturnal frontal lobe seizures. 154
Frequency of Parasomnias in patients with Nocturnal Frontal Lobe Epilepsy (NFLE) and their relatives. 153
Interobserver reliability of video-polysomnographic diagnosis of Nocturnal Frontal Lobe seizures. 152
A pragmatic approach to test the reliaility af permanent impairment classification 150
L'analisi dell'accordo fra osservatori e delle fonti di variabilità come strumento per il miglioramento della qualità in medicina legale 149
Nocturnal baroreflex sensitivity and heart rate variability are markers of excessive daytime sleepiness in sleep related breathing disorders. 145
Resilience and its correlates in patients with narcolepsy type 1 144
Heart Rate Variability as a Tool for Seizure Prediction: A Scoping Review 144
L'analisi dell'accordo fra osservatori e delle fonti di variabilità come strumento per il miglioramento della qualità in medicina legale 144
Diagnostic accuracy of clinical history in the diagnosis of Nocturnal Frontal Lobe seizures. 141
Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. 139
Nocturnal frontal lobe epilepsy and arousal disorders: chance association or common mechanisms? 136
Impaired cortical and autonomic arousal during sleep in multiple system atrophy. 134
Restless legs syndrome and periodic limb movement disorder 132
Valutazione medico-legale del danno biologico nella persona anziana. I risultati della consensus conference multidisciplinare 114
Reliability of narcolepsy assessment for disability benefit 112
In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients 106
Sleep-related hypermotor epilepsy: Long-term outcome in a large cohort 101
Interobserver reliability in the assessment of disablement in patients with narcolepsy 100
Interrater reliability as quantitative end-point for legal medicine in work ability assessment: a lesson from an epidemiological study applied to a neurological disease 89
null 85
Reliability and diagnostic accuracy of home video recording in differentiating sleep-related hypermotor epilepsy from disorders of arousal 79
Epidemiological survey on status epilepticus in Bologna and Lugo di Romagna: Incidence, prognosis and treatment 73
Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient 60
The challenge of ultra-rarity: Dual diagnosis of Lafora disease and developmental encephalopathies linked to TRIO and SHANK3 pathogenic variants 53
New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment 50
Letter to the Editor: “Record-Linkage in Population Studies on Epilepsy: Pros and Cons” 38
Quality of life and disability in pure autonomic failure: More than a prodromal synucleinopathy 38
null 1
Totale 11.755
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.063
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 0 119
2021/20221.091 96 52 67 73 87 62 29 66 37 121 233 168
2022/20231.240 127 220 78 160 78 98 29 63 178 41 99 69
2023/2024429 45 64 27 60 29 78 16 31 10 32 13 24
2024/20251.442 55 211 118 101 259 70 87 32 15 97 76 321
2025/20265.060 460 412 375 297 453 202 385 110 753 319 1.028 266
Totale 11.755